Department of Radiology, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA, 19104, USA.
Department of Pathology, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA, 19104, USA.
Radiol Med. 2018 Apr;123(4):254-259. doi: 10.1007/s11547-017-0841-8. Epub 2017 Dec 16.
To compare the concordance between fine-needle aspiration and core biopsies for osseous lesions by lesion imaging appearance and CT attenuation.
Retrospective review of 215 FNAs of osseous lesions performed in conjunction with core biopsy at our institution over a 6-year period (2011-2016). FNAs were interpreted independently of core biopsies. We assessed if FNA in conjunction with core biopsy increased diagnostic accuracy compared to core biopsy alone. We also calculated the concordance between FNA and core biopsy by lesion appearance, lesion CT attenuation, lesion histology, lesion location and FNA needle gauge size.
Core biopsy alone provided the diagnosis in 207/215 cases (96.3%), however, the FNA provided the diagnosis in the remaining 8/215 cases (3.7%) where the core biopsy was non-diagnostic. There were 154 (71.6%) lytic lesions, 21 (9.8%) blastic lesions, 25 (11.6%) mixed lytic and blastic lesions and 15 (7.0%) lesions that were neither lytic nor blastic. The concordance between FNA and core biopsy for lytic osseous lesions (136/154 cases, 88.3%) was statistically significantly higher than that for blastic osseous lesions (13/21 cases, 61.9%) [P = 4.2 × 10; 95% CI (0.02, 0.50)]. The concordance between FNA and core biopsy was higher for low-attenuation- (110/126) than high-attenuation (58/77) lesions (P = 0.028). The concordance between FNA and core biopsy was also higher for metastases (102/119 cases, 85.7%) than non-metastases (78/96, 81.3%) [P = 0.487; 95% CI (- 0.15, 0.065)]. There was no difference in the rate of concordance between FNA and core biopsy by lesion location or FNA needle gauge size (P > 0.05).
FNA with core biopsy increases diagnostic rate compared to core biopsy alone or FNA alone. The concordance between FNA and core biopsy is higher for lytic lesions than for blastic lesions; and higher for low-attenuation lesions than for high-attenuation lesions.
通过病变影像学表现和 CT 衰减值比较细针抽吸与核心活检对骨病变的一致性。
回顾性分析 2011 年至 2016 年在我院进行的 215 例骨病变的细针抽吸与核心活检,共 6 年。细针抽吸与核心活检独立进行,我们评估了与核心活检相比,细针抽吸与核心活检联合应用是否提高了诊断准确性。我们还通过病变外观、病变 CT 衰减值、病变组织学、病变位置和细针穿刺针大小计算了细针抽吸与核心活检的一致性。
仅核心活检即可提供诊断的有 207/215 例(96.3%),但在其余 8/215 例(3.7%)中,核心活检结果非诊断性,此时细针抽吸即可提供诊断。154 例(71.6%)为溶骨性病变,21 例(9.8%)为成骨性病变,25 例(11.6%)为混合性溶骨和成骨性病变,15 例(7.0%)为既非溶骨也非成骨性病变。溶骨性病变的细针抽吸与核心活检一致性(136/154 例,88.3%)明显高于成骨性病变(13/21 例,61.9%)[P=4.2×10;95%CI(0.02,0.50)]。低衰减病变(110/126)的细针抽吸与核心活检一致性高于高衰减病变(58/77)[P=0.028]。转移瘤(102/119 例,85.7%)的细针抽吸与核心活检一致性高于非转移瘤(78/96,81.3%)[P=0.487;95%CI(-0.15,0.065)]。病变位置或细针穿刺针大小对细针抽吸与核心活检的一致性无影响(P>0.05)。
与单独进行核心活检或细针抽吸相比,细针抽吸与核心活检联合应用可提高诊断率。细针抽吸与核心活检的一致性在溶骨性病变中高于成骨性病变,在低衰减病变中高于高衰减病变。